Rainer Boxhammer
Impact in
- Transplantation top 5%
- Renal Transplantation Outcomes and Treatments
- Hematology top 10%
- Multiple Myeloma Research and Treatments
Papers in
-
- Multiple Myeloma Research and Treatments 6
-
- Renal Diseases and Glomerulopathies 5
- Co-authors
- Jan Endell (6 shared papers)Cornelia Wurzenberger (1 shared paper)Johannes Weirather (1 shared paper)Brad H. Rovin (3 shared papers)Alfred Morgenstern (1 shared paper)Hermine Agis (2 shared papers)Frank Bruchertseifer (1 shared paper)Annette Feuchtinger (1 shared paper)
- Journals
- Blood (4 papers)Journal of the American Society of Nephrology (3 papers)Kidney International Reports (2 papers)Frontiers in Immunology (1 paper)Nephrology Dialysis Transplantation (1 paper)
- Partner nations
- GermanyUnited StatesAustria
In The Last Decade
Rainer Boxhammer
20 papers receiving 407 citations
Rainer Boxhammer's Hit Papers
Peers
Comparison fields: 5 of 28
- Transplantation 110
- Hematology 133
- Nephrology 53
- Genetics 18
- Radiology, Nuclear Medicine and Imaging 44
Countries citing papers authored by Rainer Boxhammer
This map shows the geographic impact of Rainer Boxhammer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rainer Boxhammer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rainer Boxhammer more than expected).
Fields of papers citing papers by Rainer Boxhammer
This network shows the impact of papers produced by Rainer Boxhammer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rainer Boxhammer. The network helps show where Rainer Boxhammer may publish in the future.
Co-authors
The 25 scholars most cited alongside Rainer Boxhammer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | A Randomized Phase 2 Trial of Felzartamab in Antibody-Mediated Rejection Hit paper breakdown → | 2024 | 103 |
| 2 | 2014 | 44 | |
| 3 | 2018 | 38 | |
| 4 | 2012 | 33 | |
| 5 | 2016 | 32 | |
| 6 | 2025 | 23 | |
| 7 | 2015 | 22 | |
| 8 | 2024 | 22 | |
| 9 | 2017 | 21 | |
| 10 | 2022 | 19 | |
| 11 | 2024 | 11 | |
| 12 | 2011 | 10 | |
| 13 | 2022 | 10 | |
| 14 | 2014 | 8 | |
| 15 | 2022 | 8 | |
| 16 | 2023 | 4 | |
| 17 | 2021 | 1 | |
| 18 | 2023 | 1 | |
| 19 | 2024 | 1 | |
| 20 | 2024 | 1 |
About Rainer Boxhammer
Rainer Boxhammer is a scholar working on Hematology, Nephrology, Radiology, Nuclear Medicine and Imaging, Transplantation and Pathology and Forensic Medicine, having authored 20 papers that have together received 412 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (6 papers), Renal Diseases and Glomerulopathies (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Renal Transplantation Outcomes and Treatments (2 papers), Lymphoma Diagnosis and Treatment (2 papers), Radiopharmaceutical Chemistry and Applications (1 paper), Immune Cell Function and Interaction (1 paper) and CAR-T cell therapy research (1 paper). The work is most often cited by research in Transplantation (110 citations), Hematology (133 citations), Nephrology (53 citations), Genetics (18 citations) and Radiology, Nuclear Medicine and Imaging (44 citations). Rainer Boxhammer has collaborated with scholars based in Germany, United States and Austria. Frequent co-authors include Jan Endell, Cornelia Wurzenberger, Johannes Weirather, Brad H. Rovin, Alfred Morgenstern, Hermine Agis, Frank Bruchertseifer, Annette Feuchtinger, Pierre Marie Ronco and Manik Chatterjee. Their work appears in journals such as Blood, Journal of the American Society of Nephrology, Kidney International Reports, Frontiers in Immunology and Nephrology Dialysis Transplantation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.